Topics

Companies Related to "2019 Diabetic Neuropathic Foot Ulcers Clinical Trials Guide" [Most Relevant Company Matches] RSS

12:11 EST 17th January 2020 | BioPortfolio

Here are the most relevant search results for "2019 Diabetic Neuropathic Foot Ulcers Clinical Trials Guide" found in our extensive corporate database of over 50,000 company records.

Showing "2019 Diabetic Neuropathic Foot Ulcers Clinical Trials Guide" Companies 1–25 of 6,000+

Extremely Relevant

Derma Sciences Inc.

Derma Sciences is a tissue regeneration company focused on advanced wound and burn care. It offers a line of products with patented technologies to help better manage chronic and hard-to-heal wounds, many of which result from diabetes and poor vascular functioning. The company recently entered the $500 million market for skin substitute products with its l...


Celleration, Inc.

Celleration, Inc., a privately held medical device company, was founded in 1999 to develop and commercialize its therapeutic ultrasound platform. The patented MIST Technology delivers non-contact, low-frequency, low-intensity ultrasound to the patient's injured soft tissue in a painless fashion. The chronic diabetic foot ulcer market had been the Company's initial focus. MIST Therapy(R) has since ...

Relevant

Immunosyn Corporation

La Jolla, CA-headquartered Immunosyn Corporation (OTC Bulletin Board: IMYN) plans to market and distribute life enhancing therapeutics. Currently, the company has exclusive worldwide rights from its largest shareholder, Argyll Biotechnologies, LLC, to market, sell and distribute SF-1019, a compound that was developed from extensive research into Biological Response Modifiers (BRMs). Argyll B...


Oculus Innovative Sciences

Oculus Innovative Sciences is pioneering innovative sciences resulting in breakthrough advances in technology. The revolutionary Microcyn® Technology, the company’s first commercialized technology, is now available in various formulations in the United States. Dermacyn® Wound Care is a super-oxidized solution for moistening, lubricating, cleaning and debriding acute and chronic wounds includin...

Lotus Tissue Repair, Inc.

Lotus Tissue Repair, Inc. is developing its proprietary recombinant collagen type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions. The company’s lead program is the first and only prot...

NephroGenex, Inc.

NephroGenex (www.nephrogenex.com) is a drug development company focusing on kidney disease. More than 20 million Americans have some form of chronic kidney disease, and over 400,000 in the US have end stage renal disease requiring dialysis, making renal disease one of the costliest illnesses to treat. The Company is developing Pyridorin(TM) (pyridoxamine dihydrochloride) as a treatment to slow t...

MacroChem Corporation

MacroChem is a specialty pharmaceutical company that develops and seeks to commercialize pharmaceutical products. Product candidates in our clinical development portfolio are: pexiganan, EcoNail(R) and SR9025 which was recently acquired. Pexiganan, a novel topical anti-infective for the treatment of diabetic foot infection, was recently in-licensed and has already completed two Phase 3 trial...

SANUWAVE Health, Inc.

SANUWAVE Health, Inc. (www.sanuwave.com) is an emerging regenerative medicine company focused on the development and commercialization of non-invasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE’s portfolio of products and product candidates activate biologic sign...

Doctor Diabetic Supply, Inc.

Doctor Diabetic Supply, Inc. is a medical supply distribution company headquartered in Miami, FL. Doctor Diabetic Supply employs over 260 people and serves more than 80,000 customers nationwide. The company is a leading direct-to-consumer provider of diabetic testing supplies and related products. Founded in 2001, Doctor Diabetic Supply, Inc. has grown to be one of the largest diabetic supply comp...

Izun Pharmaceuticals Corporation

Izun Pharmaceuticals is a US based pharmaceutical company with a wholly owned R&D center in Israel. Izun’s technology platform allows it to develop botanical drugs by optimizing and purifying the extracted botanical compounds to yield polymolecular drug candidates. These patented products are designed to impact on multiple specific receptor targets. T...

Athenagen, Inc

Athenagen, Inc., located in South San Francisco, is engaged in the development of small-molecule drugs that act on the nicotinic acetylcholine (nACh) receptor pathway. The company's lead nACh receptor agonists and antagonists are being developed to treat diseases associated with enhanced or impaired angiogenesis and in diseases where cognitive deficit plays a significant role. Athenagen currently ...

Afferon Corporation

Afferon is a privately held pharmaceutical company building a specialty pharmaceutical business focused on urology. Afferon has completed the necessary pre-clinical work on its lead candidate, resiniferatoxin, and has shown proof of principle in Phase I/IIa human clinical trials in urinary urge incontinence and diabetic neuropathy pain. Several large Phase II trials are underway in the U.S. and ...

Aurogen's technology

Aurogen's technology involves breakthrough medicine that can reduce health care costs in global markets with multibillion dollar potential and without competing comparable products. The lead product is a newly patented pharmaceutical treatment for diabetic neuropathy. Plans for product manufacture and development, including drafts of phase I/II clinical trials, have been prepared. An exciting seco...

NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals is focused on neurodegenerative diseases that affect millions of patients worldwide. The company’s novel lead candidate NB-01 is a potential treatment for diabetic neuropathic pain. NB-01 increases levels of the neurotrophin, nerve growth factor (NGF). NGF inhibits nerve cell death and promotes nerve regeneration. The compound...

Newron Pharmaceuticals SpA

Newron Pharmaceuticals SpA is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule drugs for the treatment of central nervous system (CNS) diseases. Our clinical focus is on Parkinson's disease and pain. We were established in 1999 as a spin-off from Pharmacia & Upjohn and are headquartered in Bresso, near Milan, Italy. We are conducting Phase III c...

Devon Medical, Inc.

Devon Medical, Inc. (www.devonmedicalproducts.com) is an ISO 13485 certified medical device manufacturer, designer, and distributor. Since 2005, we have developed innovative and high-quality medical devices that are affordable for healthcare markets and patients worldwide. Our exclusive therapeutic devices treat and prevent various types of wounds and heal...

Sangamo BioSciences, Inc.

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has two Phase 1 clinical tri...

BioStratum Incorporated

BioStratum is focused on the discovery, development and commercialization of novel therapeutic agents for the treatment of diabetes and diabetic complications. BioStratum's pipeline is led by Pyridorin™ a small molecule drug for the treatment of diabetic kidney disease, followed by pre-clinical compounds that will treat other diabetic complications and cancer. Pyridorin has been granted Fast Tra...

Verified Clinical Trials, LLC

Verified Clinical Trials (VCT) was developed by experts active in the clinical research community to proactively improve clinical research participant safety and data quality in clinical research trials. Verified Clinical Trials defines itself as the world's leader in the field of database registries in clinical trial research, and is the only clinical res...

Taxus Cardium Pharmaceuticals Group Inc.

Taxus Cardium Pharmaceuticals Group Inc. is a holding company that operates Cardium Therapeutics, a development stage advanced regenerative therapeutics company focused on the late-stage clinical and commercial development of regenerative medicine therapeutics including: (1) Generx®, an interventional cardiology, angiogenic gene therapy product candidate ...

Lakewood-Amedex Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Sta...

Lakewood-Amedex, Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Sta...

High Point Clinical Trials Center

High Point Clinical Trials Center is a leading clinical research unit focused on the conduct of early stage clinical pharmacology and POC Studies for biotechnology and pharmaceutical companies worldwide. The dedicated trials facility specializes in the execution of Phase I-III clinical trials.

Pharmacopeia Drug Discovery

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independently and with partners. Pharmacopeia's most advanced internal program is a dual-acting angiotensin and endothelin receptor antagonist (DARA) for hypertension and diabetic kidney disease for which Phase...

Devon Medical Products, Inc.

Devon Medical Products, Inc. (www.devonmedicalproducts.com) is an ISO 13485 medical device manufacturer, designer, and distributor. Since 2005, we have developed innovative and high-quality medical devices that are affordable for healthcare markets and patients worldwide. Our exclusive therapeutic devices treat and prevent various types of wounds and healt...


More From BioPortfolio on "2019 Diabetic Neuropathic Foot Ulcers Clinical Trials Guide"

Quick Search

Corporate Database Quicklinks